Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 289

1.

Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling.

Oh YS, Jun HS.

Int J Mol Sci. 2017 Dec 22;19(1). pii: E26. doi: 10.3390/ijms19010026. Review.

2.

GLP-1 response to sequential mixed meals: influence of insulin resistance.

Rebelos E, Astiarraga B, Bizzotto R, Mari A, Manca ML, Gonzalez A, Mendez A, Martinez CA, Hurwitz BE, Ferrannini E.

Clin Sci (Lond). 2017 Dec 4;131(24):2901-2910. doi: 10.1042/CS20171409. Print 2017 Dec 15.

PMID:
29097626
3.

The Role of GLP-1 in the Metabolic Success of Bariatric Surgery.

Hutch CR, Sandoval D.

Endocrinology. 2017 Dec 1;158(12):4139-4151. doi: 10.1210/en.2017-00564. Review.

PMID:
29040429
4.

Glucagon, a key factor in the pathophysiology of type 2 diabetes.

Girard J.

Biochimie. 2017 Dec;143:33-36. doi: 10.1016/j.biochi.2017.10.004. Epub 2017 Oct 9. Review.

PMID:
29024725
5.

Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.

Dai C, Hang Y, Shostak A, Poffenberger G, Hart N, Prasad N, Phillips N, Levy SE, Greiner DL, Shultz LD, Bottino R, Kim SK, Powers AC.

J Clin Invest. 2017 Oct 2;127(10):3835-3844. doi: 10.1172/JCI91761. Epub 2017 Sep 18.

6.

Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons.

Iwasaki Y, Goswami C, Yada T.

Neuropeptides. 2017 Oct;65:77-82. doi: 10.1016/j.npep.2017.05.003. Epub 2017 May 25.

PMID:
28624122
7.

Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway.

Shawe-Taylor M, Kumar JD, Holden W, Dodd S, Varga A, Giger O, Varro A, Dockray GJ.

Peptides. 2017 May;91:49-57. doi: 10.1016/j.peptides.2017.03.008. Epub 2017 Mar 29.

PMID:
28363795
8.

Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

Nielsen S, Svane MS, Kuhre RE, Clausen TR, Kristiansen VB, Rehfeld JF, Holst JJ, Madsbad S, Bojsen-Moller KN.

Physiol Rep. 2017 Feb;5(3). pii: e13140. doi: 10.14814/phy2.13140. Epub 2017 Feb 14.

9.

Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men.

Asmar A, Asmar M, Simonsen L, Madsbad S, Holst JJ, Hartmann B, Sorensen CM, Bülow J.

Physiol Rep. 2017 Feb;5(3). pii: e13073. doi: 10.14814/phy2.13073.

10.

Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.

Li XN, Bu HM, Ma XH, Lu S, Zhao S, Cui YL, Sun J.

Exp Clin Endocrinol Diabetes. 2017 Feb;125(2):91-97. doi: 10.1055/s-0042-112368. Epub 2016 Dec 22.

PMID:
28008585
11.

Influence of glucagon-like peptide 2 on energy homeostasis.

Baldassano S, Amato A, Mulè F.

Peptides. 2016 Dec;86:1-5. doi: 10.1016/j.peptides.2016.09.010. Epub 2016 Sep 21. Review.

PMID:
27664588
12.

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma.

Wewer Albrechtsen NJ, Hornburg D, Albrechtsen R, Svendsen B, Toräng S, Jepsen SL, Kuhre RE, Hansen M, Janus C, Floyd A, Lund A, Vilsbøll T, Knop FK, Vestergaard H, Deacon CF, Meissner F, Mann M, Holst JJ, Hartmann B.

EBioMedicine. 2016 May;7:112-20. doi: 10.1016/j.ebiom.2016.03.034. Epub 2016 Mar 31.

13.

Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk.

Bozzetto L, Annuzzi G, Ragucci M, Di Donato O, Della Pepa G, Della Corte G, Griffo E, Anniballi G, Giacco A, Mancini M, Rivellese AA.

Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):623-629. doi: 10.1016/j.numecd.2016.01.011. Epub 2016 Apr 14.

PMID:
27134062
14.

Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption.

Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PF, Ruhé HG, Barkhof F, Diamant M, Ijzerman RG.

J Endocrinol. 2016 Apr;229(1):1-12. doi: 10.1530/JOE-15-0461. Epub 2016 Jan 14.

PMID:
26769912
15.

Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.

Wang XL, Ye F, Li J, Zhu LY, Feng G, Chang XY, Sun K.

Saudi Med J. 2016 Jan;37(1):48-54. doi: 10.15537/smj.2016.1.12035.

16.

Evidence of Extrapancreatic Glucagon Secretion in Man.

Lund A, Bagger JI, Wewer Albrechtsen NJ, Christensen M, Grøndahl M, Hartmann B, Mathiesen ER, Hansen CP, Storkholm JH, van Hall G, Rehfeld JF, Hornburg D, Meissner F, Mann M, Larsen S, Holst JJ, Vilsbøll T, Knop FK.

Diabetes. 2016 Mar;65(3):585-97. doi: 10.2337/db15-1541. Epub 2015 Dec 15. Erratum in: Diabetes. 2016 Jun;65(6):1752.

17.

GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop.

Giacco F, Du X, Carratú A, Gerfen GJ, D'Apolito M, Giardino I, Rasola A, Marin O, Divakaruni AS, Murphy AN, Shah MS, Brownlee M.

Diabetes. 2015 Sep;64(9):3273-84. doi: 10.2337/db15-0084.

18.

Plasma levels of glucagon-like peptide 1 and markers of obesity among young and healthy adults.

van der Stouwe JG, Aeschbacher S, Krisai P, Schoen T, Meyre P, Todd J, Estis J, Risch M, Risch L, Conen D.

Clin Endocrinol (Oxf). 2015 Nov;83(5):636-42. doi: 10.1111/cen.12789. Epub 2015 Apr 27.

PMID:
25865948
19.

Glucagon--Early breakthroughs and recent discoveries.

Ahrén B.

Peptides. 2015 May;67:74-81. doi: 10.1016/j.peptides.2015.03.011. Epub 2015 Mar 23. Review.

PMID:
25814364
20.

Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy.

Kelstrup L, Clausen TD, Mathiesen ER, Hansen T, Holst JJ, Damm P.

J Clin Endocrinol Metab. 2015 May;100(5):1967-75. doi: 10.1210/jc.2014-3978. Epub 2015 Mar 17.

PMID:
25781355

Supplemental Content

Support Center